Literature DB >> 15497698

Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Tianyuan Fan1, Kozo Takayama, Yoshiyuki Hattori, Yoshie Maitani.   

Abstract

PURPOSE: To develop paclitaxel carried by injectable PEGylated emulsions, an artificial neural network (ANN) was used to optimize the formulation--which has a small particle size, high entrapment efficiency, and good stability--and to investigate the role of each ingredient in the emulsion.
METHODS: Paclitaxel emulsions were prepared by a modified ethanol injection method. A computer optimization technique based on a spherical experimental design for three-level, three factors [soybean oil (X1), PEG-DSPE (X2) and polysorbate 80 (X3)] were used to optimize the formulation. The entrapment efficiency of paclitaxel (Y1) was quantified by HPLC; the particle size of the emulsions (Y2) was measured by dynamic laser light scattering and the stability of paclitaxel emulsions was monitored by the changes in drug concentration (Y3) and particle size (Y4) after storage at 4 degrees C.
RESULTS: The entrapment efficiency, particle size and stability of paclitaxel emulsions were influenced by PEG-DSPE, polysorbate 80, and soybean oil. Paclitaxel emulsions of small size (262 nm), high entrapment efficiency (96.7%), and good stability were obtained by the optimization.
CONCLUSIONS: A novel formulation for paclitaxel emulsions was optimized with ANN and prepared. The contribution indices of each component suggested that PEG-DSPE mainly contributes to the entrapment efficiency and particle size of paclitaxel emulsions, while polysorbate 80 contributes to stability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497698     DOI: 10.1023/b:pham.0000041467.28884.16

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Application of neural computing in pharmaceutical product development.

Authors:  A S Hussain; X Q Yu; R D Johnson
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

2.  A new parenteral emulsion for the administration of taxol.

Authors:  B D Tarr; T G Sambandan; S H Yalkowsky
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.

Authors:  P Crosasso; M Ceruti; P Brusa; S Arpicco; F Dosio; L Cattel
Journal:  J Control Release       Date:  2000-01-03       Impact factor: 9.776

4.  Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.

Authors:  N V Koshkina; J C Waldrep; L E Roberts; E Golunski; S Melton; V Knight
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

5.  Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data.

Authors:  A S Hussain; R D Johnson; N N Vachharajani; W A Ritschel
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

6.  Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer.

Authors:  P C Wu; Y Obata; M Fujikawa; C J Li; K Higashiyama; K Takayama
Journal:  J Pharm Sci       Date:  2001-08       Impact factor: 3.534

7.  Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics.

Authors:  F Dosio; S Arpicco; P Brusa; B Stella; L Cattel
Journal:  J Control Release       Date:  2001-09-11       Impact factor: 9.776

8.  A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol).

Authors:  B B Lundberg
Journal:  J Pharm Pharmacol       Date:  1997-01       Impact factor: 3.765

9.  Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol.

Authors:  J J Wheeler; K F Wong; S M Ansell; D Masin; M B Bally
Journal:  J Pharm Sci       Date:  1994-11       Impact factor: 3.534

10.  Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol.

Authors:  Wang Junping; Kozo Takayama; Tsuneji Nagai; Yoshie Maitani
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  2 in total

1.  Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.

Authors:  Hima Bindu Ruttala; Young Tag Ko
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

2.  Electrochemical Behavior and Direct Quantitative Determination of Paclitaxel.

Authors:  Jiaqi Lang; Wenting Wang; You Zhou; Dongqin Guo; Rujie Shi; Nong Zhou
Journal:  Front Chem       Date:  2022-04-26       Impact factor: 5.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.